• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Understanding Differences in Sex-Based Outcomes with Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.

作者信息

Akin Ibrahim, Hamdani Nazha, El-Battrawy Ibrahim

机构信息

Section of Invasive Cardiology and Electrophysiology, I. Department of Internal Medicine, University Mannheim, Medical Faculty Mannheim, University Heidelberg, Theodor-Kutzer Ufer 1-3, 68167, Mannheim, Germany.

Institute of Physiology, Department of Cellular and Translational Physiology and Institute for Research and Education (IFL), Molecular and Experimental Cardiology, Ruhr-University Bochum, Bochum, Germany.

出版信息

Drugs. 2024 Jun;84(6):703-705. doi: 10.1007/s40265-024-02041-4. Epub 2024 May 29.

DOI:10.1007/s40265-024-02041-4
PMID:38809374
Abstract
摘要

相似文献

1
Understanding Differences in Sex-Based Outcomes with Dual Antiplatelet Therapy After Percutaneous Coronary Intervention.经皮冠状动脉介入治疗后双重抗血小板治疗中基于性别的结果差异分析
Drugs. 2024 Jun;84(6):703-705. doi: 10.1007/s40265-024-02041-4. Epub 2024 May 29.
2
Sex-Based Outcomes of Dual-Antiplatelet Therapy After Percutaneous Coronary Intervention: A Pairwise and Network Meta-Analysis.经皮冠状动脉介入治疗后双联抗血小板治疗的性别结局：成对和网络荟萃分析。
Drugs. 2024 Jun;84(6):685-701. doi: 10.1007/s40265-024-02034-3. Epub 2024 May 29.
3
Comparison of 1-month vs. 12-month dual antiplatelet therapy after implantation of drug-eluting stents in patients with acute coronary syndrome: the ULTIMATE-DAPT trial.
Eur Heart J Acute Cardiovasc Care. 2024 May 7;13(4):368-369. doi: 10.1093/ehjacc/zuae048.
4
Ticagrelor monotherapy after short duration of dual antiplatelet therapy compared to continued dual antiplatelet therapy in patients with acute coronary syndromes undergoing percutaneous coronary interventions: an updated meta-analysis.替格瑞洛单药治疗与继续双联抗血小板治疗在接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者中的比较：一项更新的荟萃分析。
Coron Artery Dis. 2024 Nov 1;35(7):590-597. doi: 10.1097/MCA.0000000000001417. Epub 2024 Aug 23.
5
Use of Administrative Claims Data to Estimate Treatment Effects for 30 Versus 12 Months of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: Findings From the EXTEND-DAPT Study.利用行政索赔数据评估经皮冠状动脉介入治疗后30个月与12个月双联抗血小板治疗的疗效：EXTEND-DAPT研究结果
Circulation. 2020 Jul 21;142(3):306-308. doi: 10.1161/CIRCULATIONAHA.120.047729. Epub 2020 Jul 20.
6
Antiplatelet Strategy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.急性冠状动脉综合征行经皮冠状动脉介入治疗患者的抗血小板策略：系统评价和网络荟萃分析。
J Am Heart Assoc. 2024 Oct 15;13(20):e032490. doi: 10.1161/JAHA.122.032490. Epub 2024 Oct 11.
7
Dual Antiplatelet and Anticoagulation Regimens for Women Undergoing Percutaneous Coronary Intervention.女性经皮冠状动脉介入治疗中的双联抗血小板和抗凝治疗方案。
Interv Cardiol Clin. 2025 Jan;14(1):29-36. doi: 10.1016/j.iccl.2024.08.012. Epub 2024 Oct 10.
8
Determinants and Clinical Outcomes of Extended Dual Antiplatelet Therapy over 3 Years after Drug-Eluting Stent Implantation: A Retrospective Analysis.药物洗脱支架置入后 3 年以上延长双联抗血小板治疗的决定因素和临床结局：回顾性分析。
Yonsei Med J. 2020 Jul;61(7):597-605. doi: 10.3349/ymj.2020.61.7.597.
9
Ticagrelor alone versus ticagrelor plus aspirin from month 1 to month 12 after percutaneous coronary intervention in patients with acute coronary syndromes (ULTIMATE-DAPT): a randomised, placebo-controlled, double-blind clinical trial.替格瑞洛单用或替格瑞洛加阿司匹林用于急性冠脉综合征患者经皮冠状动脉介入治疗后 1 至 12 个月（ULTIMATE-DAPT）：一项随机、安慰剂对照、双盲临床试验。
Lancet. 2024 May 11;403(10439):1866-1878. doi: 10.1016/S0140-6736(24)00473-2. Epub 2024 Apr 7.
10
Indobufen versus aspirin after percutaneous coronary intervention in elderly patients with acute coronary syndrome.吲哚布芬与阿司匹林用于老年急性冠状动脉综合征患者经皮冠状动脉介入治疗后的比较
BMC Cardiovasc Disord. 2025 Jul 7;25(1):495. doi: 10.1186/s12872-025-04843-0.

本文引用的文献

1
The impact of diabetes mellitus on the outcome of troponin-positive patients with non-obstructive coronary arteries.糖尿病对肌钙蛋白阳性的非阻塞性冠状动脉患者预后的影响。
Int J Cardiol Heart Vasc. 2024 Feb 2;50:101350. doi: 10.1016/j.ijcha.2024.101350. eCollection 2024 Feb.
2
Sex-Related Differences in Patients at High Bleeding Risk Undergoing Percutaneous Coronary Intervention: A Patient-Level Pooled Analysis From 4 Postapproval Studies.经皮冠状动脉介入治疗中高出血风险患者的性别相关差异：4 项批准后研究的患者水平汇总分析。
J Am Heart Assoc. 2020 Apr 7;9(7):e014611. doi: 10.1161/JAHA.119.014611. Epub 2020 Mar 30.
3
Gender differences in the association between body mass index and health-related quality of life among adults:a cross-sectional study in Shandong, China.
中国山东成年人中体质指数与健康相关生活质量之间的关联存在性别差异：一项横断面研究。
BMC Public Health. 2019 Jul 31;19(1):1021. doi: 10.1186/s12889-019-7351-7.
4
Impact of Gender and Door-to-Balloon Times on Long-Term Mortality in Patients Presenting With ST-Elevation Myocardial Infarction.性别和 Door-to-Balloon 时间对 ST 段抬高型心肌梗死患者长期死亡率的影响。
Am J Cardiol. 2019 Sep 15;124(6):833-841. doi: 10.1016/j.amjcard.2019.06.008. Epub 2019 Jun 24.
5
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
Eur Heart J. 2019 Jan 7;40(2):87-165. doi: 10.1093/eurheartj/ehy394.
6
Platelet function and long-term antiplatelet therapy in women: is there a gender-specificity? A 'state-of-the-art' paper.血小板功能与女性长期抗血小板治疗：是否存在性别特异性？一篇“最新技术”论文。
Eur Heart J. 2014 Sep 1;35(33):2213-23b. doi: 10.1093/eurheartj/ehu279. Epub 2014 Jul 14.
7
Do gender differences in primary PCI mortality represent a different adherence to guideline recommended therapy? a multicenter observation.直接经皮冠状动脉介入治疗（PCI）死亡率中的性别差异是否代表对指南推荐治疗的不同依从性？一项多中心观察研究。
BMC Cardiovasc Disord. 2014 Jun 2;14:71. doi: 10.1186/1471-2261-14-71.
8
Quantification of incomplete revascularization and its association with five-year mortality in the synergy between percutaneous coronary intervention with taxus and cardiac surgery (SYNTAX) trial validation of the residual SYNTAX score.定量评价血运重建不完全与 SYNTAX 试验中经皮冠状动脉介入治疗与心脏手术联合治疗（SYNTAX）验证残余 SYNTAX 评分 5 年死亡率之间的关系。
Circulation. 2013 Jul 9;128(2):141-51. doi: 10.1161/CIRCULATIONAHA.113.001803. Epub 2013 Jun 13.
9
Platelet biology and response to antiplatelet therapy in women: implications for the development and use of antiplatelet pharmacotherapies for cardiovascular disease.血小板生物学和抗血小板治疗反应在女性中的作用：对开发和使用抗血小板药物治疗心血管疾病的影响。
J Am Coll Cardiol. 2012 Mar 6;59(10):891-900. doi: 10.1016/j.jacc.2011.09.075.
10
Impact of race and gender on antithrombotic therapy.种族和性别对抗血栓治疗的影响。
Thromb Haemost. 2010 Sep;104(3):471-84. doi: 10.1160/TH10-04-0232. Epub 2010 Jul 20.